Page 267 - วารสารการแพทย์แผนไทยและการแพทย์ ทางเลือก ปีที่ 19 ฉบับที่ 2 พฤษภาคม-สิงหาคม 2564
P. 267

J Thai Trad Alt Med                                   Vol. 19  No. 2  May-Aug  2021  497




                Acarbose treatment and the risk of cardiovascular   macrophage infiltration by inhibiting NF-kappaB activa-
                disease and hypertension in patients with impaired   tion and proinflammatory cytokines in streptozotocin
                glucose tolerance: the STOP-NIDDM trial. JAMA.   induced-diabetic nephropathy. Nutr Metab (Lond).
                2003;290(4):486-94.                         2011;8(1):35.
              11.  Chuengsamarn S, Rattanamongkolgul S, Luechapu-    23.  Suryanarayana P, Satyanarayana A, Balakrishna N,
                diporn R, Phisalaphong C, Jirawatnotai S. Curcumin   Kumar PU, Reddy GB. Effect of turmeric and cur-
                extract for prevention of type 2 diabetes. Diabetes Care.   cumin on oxidative stress and antioxidant enzymes in
                2012;35(11):2121-7.                         streptozotocin-induced diabetic rat. Med Sci Monit.
              12.  Zheng B, Yang L, Wen C, Huang X, Xu C, Lee KH, Xu J.   2007;13(12):BR286-92.
                Curcumin analog L3 alleviates diabetic atherosclerosis     24.  Chougala MB, Bhaskar JJ, Rajan MG, Salimath PV.
                by multiple effects. Eur J Pharmacol. 2016;775:22-34.  Effect of curcumin and quercetin on lysosomal enzyme
              13.  Rosak C, Mertes G. Critical evaluation of the role of   activities in streptozotocin-induced diabetic rats. Clin
                acarbose in the treatment of diabetes: patient consid-  Nutr. 2012;31(5):749-55.
                erations. Diabetes Metab Syndr Obes. 2012;5:357-67.    25.  Nishiyama T, Mae T, Kishida H, Tsukagawa M, Mi-
              14.  Gupta SC, Patchva S, Koh W, Aggarwal BB. Discovery   maki Y, Kuroda M, Sashida Y, Takahashi K, Kawada T,
                of curcumin, a component of golden spice, and its   Nakagawa K, Kitahara M. Curcuminoids and sesqui-
                miraculous biological activities. Clin Exp Pharmacol   terpenoids in turmeric (Curcuma longa L.) suppress an
                Physiol. 2012;39(3):283-99.                 increase in blood glucose level in type 2 diabetic KK-Ay
              15.  Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as   mice. J Agric Food Chem. 2005;53(4):959-63.
                “Curecumin”: from kitchen to clinic. Biochem Pharma-    26.  Seo KI, Choi MS, Jung UJ, Kim HJ, Yeo J, Jeon SM, Lee
                col. 2008;75(4):787-809.                    MK. Effect of curcumin supplementation on blood glu-
              16.  Anand P, Kunnumakkara AB, Newman RA, Aggarwal   cose, plasma insulin, and glucose homeostasis related
                BB. Bioavailability of curcumin: problems and promises.   enzyme activities in diabetic db/db mice. Mol Nutr Food
                Mol Pharm. 2007;4(6):807-18.                Res. 2008;52(9):995-1004.
              17.  Devassy JG, Nwachukwu ID, Jones PJ. Curcumin and     27.  He HJ, Wang GY, Gao Y, Ling WH, Yu ZW, Jin TR.
                cancer: barriers to obtaining a health claim. Nutr Rev.   Curcumin attenuates Nrf2 signaling defect, oxidative
                2015;73(3):155-65.                          stress in muscle and glucose intolerance in high fat
              18.  ClinicalTrials.gov. Improved oral bioavailability of   diet-fed mice. World J Diabetes. 2012;3(5):94-104.
                curcumin incorporated into micelles. [Internet]. [cited     28.  National Drug System Development Committee. Na-
                2020 Jan 19]; Available from: https://clinicaltrials.gov/  tional Lists of Essential Medicine B.E. 2549. [Internet].
                ct2/show/NCT01982734?term=curcumin&rank=5.  [cited 2019 Apr 26]; Available from: http://drug.fda.
              19.  Zhang DW, Fu M, Gao SH, Liu JL. Curcumin and dia-  moph.go.th:81/nlem.in.th/sites/default/files/binder3.pdf.
                betes: a systematic review. Evid Based Complement     29.  Xu K, Al-Ani MK, Pan X, Chi Q, Dong N, Qiu X. Plant-
                Alternat Med. 2013;2013:636053.             derived products for treatment of vascular intima
              20.  El-Azab MF, Attia FM, El-Mowafy AM. Novel role of cur-  hyperplasia selectively inhibit vascular smooth muscle
                cumin combined with bone marrow transplantation in   cell functions. Evid Based Complement Alternat Med.
                reversing experimental diabetes: Effects on pancreatic   2018;2018:3549312.
                islet regeneration, oxidative stress, and inflammatory     30.  Rashid Jusoh A, Das S, Kamsiah J, Qodriyah HM,
                cytokines. Eur J Pharmacol. 2011;658(1):41-8.  Faizah O. Effect of curcumin on aortic changes in
              21.  El-Moselhy MA, Taye A, Sharkawi SS, El-Sisi SF, Ahmed   ovariectomized rats fed with repeatedly heated soy
                AF. The antihyperglycemic effect of curcumin in high   oil: a preliminary electron microscopic study. Clin Ter.
                fat diet fed rats. Role of TNF-alpha and free fatty acids.   2013;164(4):307-13.
                Food Chem Toxicol. 2011;49(5):1129-40.    31.  Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A,
              22.  Soetikno V, Sari FR, Veeraveedu PT, Thandavarayan   Petticrew M, Shekelle P, Stewart LA, PRISMA-P Group.
                RA, Harima M, Sukumaran V, Lakshmanan AP, Su-  Preferred reporting items for systematic review and
                zuki K, Kawachi H, Watanabe K. Curcumin ameliorates   meta-analysis protocols (PRISMA-P) 2015 statement.
   262   263   264   265   266   267   268   269   270   271   272